Rampart Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-36,453
Closed -$1.27M 278
2020
Q3
$1.27M Sell
36,453
-68,141
-65% -$2.39M 0.8% 21
2020
Q2
$3.25M Buy
104,594
+58,406
+126% +$1.98M 0.55% 38
2020
Q1
$1.43M Sell
46,188
-21,972
-32% -$749K 0.68% 27
2019
Q4
$2.53M Buy
68,160
+1,577
+2% +$56.2K 0.31% 100
2019
Q3
$2.27M Sell
66,583
-30,749
-32% -$1.12M 0.28% 112
2019
Q2
$4M Sell
97,332
-7,638
-7% -$303K 0.47% 59
2019
Q1
$4.23M Buy
104,970
+39,356
+60% +$1.58M 0.48% 54
2018
Q4
$2.72M Sell
65,614
-18,564
-22% -$771K 0.75% 31
2018
Q3
$2.86M Sell
84,178
-2,368
-3% -$91.2K 1.25% 10
2018
Q2
$2.98M Sell
86,546
-81,188
-48% -$2.77M 0.29% 97
2018
Q1
$5.65M Buy
167,734
+90,590
+117% +$3.11M 0.54% 47
2017
Q4
$2.65M Sell
77,144
-8,977
-10% -$306K 1.02% 18
2017
Q3
$2.92M Buy
86,121
+5,454
+7% +$175K 0.99% 15
2017
Q2
$2.57M Buy
80,667
+62,905
+354% +$1.98M 0.93% 17
2017
Q1
$577K Buy
+17,762
New +$560K 0.21% 24

Other funds holding PFE

Rampart Investment Management's PFE Position: Q4 2020 in Review

Rampart Investment Management sold out of Pfizer (PFE) in Q4 2020, closing a stake of 36,453 shares — an estimated $1.27M sold.

Rampart Investment Management first reported a position in PFE in Q1 2017 and held it in 15 quarters. The position peaked at $5.65M in Q1 2018. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • Rampart Investment Management reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 36,453 Pfizer shares in Q4 2020, an estimated $1.27M.
  • Rampart Investment Management first reported a position in Pfizer in Q1 2017 and held it in 15 quarters.
  • Rampart Investment Management's Pfizer position peaked at $5.65M in Q1 2018.
  • 2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.